Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Latanoprost - Sun Pharma Advanced Research Company

Next Previous
Search
Drug Profile

Latanoprost - Sun Pharma Advanced Research Company

Alternative Names: BKC-free latanoprost; Latanoprost BAK-free eye drops; Xelpros

Latest Information Update: 21 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antiglaucomas; Eye disorder therapies; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Glaucoma

Most Recent Events

  • 05 Nov 2019 China Medical System signed a licensing agreement with Sun Pharma Advanced Research for development and commercialisation of latanoprost in China, Hong Kong, Macau and Taiwan
  • 13 Feb 2019 Launched for Glaucoma in USA (Ophthalmic), prior to February 2019
  • 18 Sep 2018 Lantanoprost opthalmic emulsion is still in pre-registration phase for Glaucoma in USA, prior September 2018

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top